Last Update Time: N/A
ISIN: INE176J01011
Sector: SERVICES
Symbol: SICAGEN

Sicagen India Limited

₹0.00 ₹0.00 (0.00%) ▲
Prev. Close ₹N/A
Open ₹0.00
Close ₹24.35
Range ₹0.00 - ₹0.00
High ₹0.00
Low ₹0.00
Ind. Close ₹0.00
VWAP ₹0.00

The current stock price of Sicagen India Limited is ₹0.00, with a target price range between ₹0.00 and ₹0.00. The stock has experienced a price change of ₹0.00 (0.00%), reflecting recent market volatility.

Today's opening price was ₹0.00, while the previous close stood at ₹0.00.

The market trend suggests an uptrend, making it an attractive investment opportunity for traders seeking short-term gains.

For real-time stock market updates, live share prices, and stock analysis, stay tuned. Understanding key stock metrics like VWAP, high-low range, and market momentum can help traders make informed investment decisions.

Sicagen India Limited Price Chart

Sicagen India Limited Pre Open Market Overview: N/A

Key Metrics:

  • IEP (Indicative Equilibrium Price): 0.00
  • Previous Close Price: 0.00
  • Change: 0.00%
  • Total Traded Volume: 0.00
  • Total Buy Quantity: 0.00
  • Total Sell Quantity: 0.00
PriceBuy QtySell Qty
0.000.000.00

ATO Data:

  • Buy Quantity (ATO): 0
  • Sell Quantity (ATO): 0

Order Book

BidQtyAskQty
0.0000.000
0.0000.000
0.0000.000
0.0000.000
0.0000.000
Total Buy Quantity: 0.00 Total Sell Quantity: 0.00

Shareholding Patterns of Sicagen India Limited

Key Trade Statistics of Sicagen India Limited

Trade InformationDetails
Traded Volume (Lakhs)N/A
Traded Value (₹ Cr.)N/A
Total Market Cap (₹ Cr.)N/A
Free Float Market Cap (₹ Cr.)N/A
Impact costN/A
Quantity TradedN/A
Deliverable QuantityN/A
% of Quantity to TradedN/A
Security VaR24.47
Index VaRN/A
VaR Margin24.47
Extreme Loss Rate3.5
Adhoc MarginN/A
Applicable Margin Rate27.97
Face Value10

Key Price Statistics of Sicagen India Limited

The 52-week high for Sicagen India Limited was ₹0.00, recorded on N/A. On the other hand, the 52-week low stands at ₹0.00, with the lowest value recorded on N/A.

The upper band for trading is ₹25.90, and the lower band is ₹23.50. The price band is No Band%.

The stock's daily volatility stands at N/A, while the annualized volatility is N/A. The tick size for trading is ₹0.00.

Price InformationDetails
52 Week High (-)0.00
52 Week Low (-)0.00
Upper Band25.90
Lower Band23.50
Price Band (%)No Band
Daily Volatility-
Annualised Volatility-
Tick Size0.00

Key Securities Statistics of Sicagen India Limited

Securities InformationDetails
StatusPermanent Suspended
Trading StatusSuspended
Date of Listing21-Aug-2008
Adjusted P/ENA
Symbol P/ENA
IndexNA
Macro-Economic SectorSERVICES
SectorSERVICES
IndustryTRADING
Basic IndustryTRADING

Security Status of Sicagen India Limited

TitleDetails
Board StatusMain
Trading SegmentNormal Market
Session No.-
Class of SharesEquity
SDD Compliance-
Name of Compliance Officer-

Announcements of Sicagen India Limited

SubjectDate
Voluntary Delisting 08-Jul-2021
Voluntary Delisting 08-Jul-2021
Certificate under SEBI (Depositories and Participants) Regulations, 2018 06-Jul-2021
Resignation 30-Jun-2021
Credit Rating 29-Jun-2021
Trading Window 29-Jun-2021
Related Party Transactions 01-Jun-2021
Financial Result Updates 26-May-2021

Corporate Actions of Sicagen India Limited

Face ValuePurposeEx-DateStart DateEnd Date
10 Dividend - Rs 0.50 Per Share10-Sep-202012-Sep-202017-Sep-2020
10 Annual General Meeting/Dividend - Rs 0.4 Per Share23-Jul-201925-Jul-201931-Jul-2019
10 Annual General Meeting / Dividend- Re 0.60 Per Share26-Jul-201828-Jul-201806-Aug-2018
10 Annual General Meeting/Dividend - Re 0.60 Per Share19-Jul-201721-Jul-201727-Jul-2017
10 Dividend - Rs 0.60 Per Share08-Sep-201612-Sep-201620-Sep-2016
10 Dividend - Re 0.60/- Per Share10-Sep-201514-Sep-201523-Sep-2015
10Annual General Meeting/Dividend Re.0.80/- Per Share31-Jul-201402-Aug-201411-Aug-2014
10Annual General Meeting / Dividend - Re 1/- Per Share19-Jul-201323-Jul-201301-Aug-2013
10Annual General Meeting/Dividend Re 1 Per Share20-Jul-201224-Jul-201202-Aug-2012
10Annual General Meeting And Dividend Re.1/- Per Share19-Jul-201121-Jul-201130-Jul-2011
10Annual General Meeting16-Jul-201020-Jul-201029-Jul-2010
10Annual General Meeting13-Aug-200917-Aug-200926-Aug-2009
10Annual General Meeting01-Sep-200804-Sep-200815-Sep-2008

Board Meetings of Sicagen India Limited

PurposeDetailsAtt.Mtg. Date
Financial ResultsTo consider and approve the financial results for the period ended Jun 30, 2021 11-Aug-2021
Financial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2021, dividend and other business matters 26-May-2021
Financial Results/Other business mattersTo consider and approve the financial results for the period ended December 31, 2020 and other business matters 10-Feb-2021
Financial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2020 and other business matters 12-Nov-2020
Financial ResultsThe meeting of the Board of Directors of the Company has been scheduled to be held on Friday, 07th August, 2020 inter alia, to consider and approve the unaudited financial results of the Company for the period ended Jun 30, 2020 07-Aug-2020
Financial ResultsThe meeting of the Board of Directors of the Company has been scheduled to be held on Friday, 07th August, 2020 inter alia, to consider and approve the unaudited financial results of the Company for the period ended Jun 30, 2020 07-Aug-2020
Financial ResultsThe meeting of the Board of Directors of the Company has been scheduled to be held on Wednesday, the 17th June 2020 inter alia, to consider the following:-ᅡᅠAudited annual accounts of the Company for the year ended 31st March 2020.Audited financial results (standalone & consolidated results) for the quarter and year ended 31st March 2020.ᅡᅠRecommendation of equity dividend if any considered for the financial year 2019-20.ᅡᅠThe above intimation may kindly be taken on record. 17-Jun-2020
Voluntary DelistingSICAGEN : 23-Apr-2020 : The Company has informed the Exchange that a Board meeting scheduled on March 31, 2020 has been now re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on April 23, 2020 through Video Conference inter alia to consider and approve the proposal for voluntary delisting of shares from National Stock Exchange (NSE). 31-Mar-2020
Voluntary DelistingTo consider and approve the proposal for voluntary delisting of equity shares of the Company from National Stock Exchange of India Ltd (NSE) as per Regulation 6(a) & 7 of the SEBI (Delisting of Equity Shares)Regulation, 2009. The equity shares of the Company will remain to be listed on Bombay stock Exchange Ltd (BSE), which has nationwide terminals. 31-Mar-2020
Financial ResultsTo consider and approve the financial results for the period ended December 31, 2019 07-Feb-2020
Financial ResultsTo consider and approve the unaudited financial results for the period ended September 30, 2019 13-Nov-2019
Financial ResultsTo consider and approve the unfinancial results for the period ended Jun 30, 2019 31-Jul-2019
Financial ResultsTo consider and approve the financial results for the period ended March 31, 2019 22-May-2019
Financial ResultsTo consider and approve the financial results for the period ended December 31, 2018 13-Feb-2019
Financial ResultsTo inter alia, consider and approve the un-audited financial results of the Company for the quarter and half year ended September 30, 2018. 22-Oct-2018
Financial ResultsTo consider and approve the un-audited financial results of the Company for the period ended Jun 30, 2018. 09-Aug-2018
Financial Results/DividendTo consider and approve the audited financial results for the quarter and year ended March 31, 2018 and equity dividend if any recommended for the year 2017-18. 15-May-2018
ResultsInter alia, to consider and approve the un-audited financial results of the Company for the quarter ended December 31, 2017. 07-Feb-2018
Resultsinteralia, to consider & approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2017 07-Dec-2017
Resultsinteralia, to consider & approve the unaudited financial results of the Company for the quarter ended June 30, 2017. 06-Sep-2017

Financial Results of Sicagen India Limited

Company Directory of Sicagen India Limited

Web AddressSM NameOfficeAddressCityPincodeTelephoneEmail
www.sicagen.comSicagen India LimitedHead Office/ Corporate Office4th Floor, SPIC House
88, Mount Road
Guindy
Chennai
CHENNAI600032044-30070300secl@sicagen.com
www.sicagen.comSicagen India LimitedRegistered Office4th Floor, SPIC House
No.88, Mount Road,
Guindy
Chennai
CHENNAI600032044-04440754075secl@sicagen.com
www.sicagen.comSicagen India LimitedTransfer AgentCameo Corporate Services Limited
Subramanian Building 5th Floor,
No 1, Club House Road,
CHENNAI600002044-28460390 (6 lines)cameo@cameoindia.com

Insider Trading of Sicagen India Limited

Reg. ClauseAcq./Disp.Sec. (No.)Sec. ValueTxn TypeBcast Time
7(2)A C MUTHIAH1929572797877Sell31-Mar-2021 16:25
7(2)ACM EDUCATIONAL FOUNDATION5720438866667Sell18-Feb-2021 17:25
7(2)SICAL LOGISTICS LTD500001810000Sell23-May-2018 19:36
7(2)SPIC OFFICERS AND WELFARE FOUNDATION16250411937.5Sell20-Feb-2017 20:02
7(2)SPIC GROUP COMPANIES EMPLOYEES WELFARE FOUNDATION16250411937.5Sell20-Feb-2017 20:02

Annual Reports of Sicagen India Limited

CompanyFrom YearTo YearAtt.
Sicagen India Limited20192020
Sicagen India Limited20182019
Sicagen India Limited20172018
Sicagen India Limited20162017
Sicagen India Limited20152016
Sicagen India Limited20142015
Sicagen India Limited20132014
Sicagen India Limited20122013
Sicagen India Limited20112012
Sicagen India Limited20102011
Sicagen India Limited20092010

Investor Complaints of Sicagen India Limited

Event Calendar of Sicagen India Limited

CompanyPurposeDetailsDate
Sicagen India LimitedResults/DividendInter-alia, to consider and approve the following:- (1) Annual Accounts of the Company for the financial year ended March 31,2011. (2) Audited Financial Results (Standalone & Consolidated Results) for the quarter and financial year ended March 31, 2011.(3) Recommendation of equity dividend, if any for the aforesaid financial year.27-May-2011
Sicagen India LimitedResults/DividendInter alia, to consider and approve the following : (1) Audited Annual Accounts of the Company for the financial year ended March 31, 2012; (2) Audited Financial Results (Standalone & Consolidated Results) for the quarter and financial year ended March 31, 2012; (3) Recommendation of equity dividend, if any for the aforesaid financial year.28-May-2012
Sicagen India LimitedResults/DividendInter alia, to consider and approve the following: (1) Audited Annual Accounts of the Company for the financial year ended March 31, 2013; (2) Audited Financial Results (Standalone & Consolidated Results) for the quarter and financial year ended March 31, 2013; (3) Recommendation of equity dividend, if any for the aforesaid financial year.08-May-2013
Sicagen India LimitedResultsInter alia, to consider & approve the un-audited financial results of the Company for the quarter ended June 30, 2013.01-Aug-2013
Sicagen India LimitedResultsTo consider & approve inter alia, the un-audited financial results of the Company for the quarter & half year ened September 30, 2013.28-Oct-2013
Sicagen India LimitedResultsInter alia to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2013.10-Feb-2014
Sicagen India LimitedResults/Dividendinter alia, to consider the following: 1. Audited Annual Accounts of the Company for the financial year ended March 31, 2014. 2. Audited Financial Results (Standalone & Consolidated Results) for the quarter and financial year ended March 31, 2014. 3. Recommendation of equity dividend, if any for the financial year ended March 31, 2014.27-May-2014
Sicagen India LimitedResultsTo consider & approve inter alia, the un-audited financial results of the Company for the quarter ended June 30, 2014.11-Aug-2014
Sicagen India LimitedResultsTo consider and approve , the un-audited financial results of the Company for the quarter ended September 30, 2014.05-Nov-2014
Sicagen India LimitedResultsTo consider and approve inter-alia the Unaudited Financial Results of the Company for the quarter ended December 31, 2014.06-Feb-2015
Sicagen India LimitedResults/DividendInter alia, to consider the following: 1)Audited Annual Accounts of the Company for the year ended March 31, 2015. 2) Audited Financial Results (Standalone & Consolidated Results) for quarter and year ended March 31, 2015. 3) Recommendation of equity dividend if any considered, for the year ended March 31, 2015.19-May-2015
Sicagen India LimitedResultsTo consider & approve, inter alia, the unaudited financial results of the Company for the quarter ended June 30, 2015.31-Jul-2015
Sicagen India LimitedResultsTo consider & approve, inter alia, the unaudited financial results of the Company for the quarter and half year ended September 30, 2015.03-Nov-2015
Sicagen India LimitedResultsto consider, inter alia, the unaudited financial results of the Company for the quarter ended December 31, 2015.01-Feb-2016
Sicagen India LimitedResults/DividendTo inter alia, consider the (i) audited financial statements for the year ended March 31, 2016 (ii) audited financial results (both standalone & consolidated results) for the quarter and year ended March 31, 2016 (iii) Recommendation of equity dividend, if any considered for the year ended March 31, 2016.25-May-2016
Sicagen India LimitedResultsinteralia, to consider & approve the unaudited financial results (both standalone & consolidated results) of the Company for the quarter ended June 30, 2016.03-Aug-2016
Sicagen India LimitedResultsinter alia, to consider and approve the unaudited financial results of the Company for the quarter and half year ended September 30, 2016.10-Nov-2016
Sicagen India LimitedResultsto consider, inter alia, the unaudited financial results of the Company for the quarter ended December 31, 2016.30-Jan-2017
Sicagen India LimitedResults/DividendInter alia, to consider the following :- -Audited Annual Accounts of the Company for the year ended March 31, 2017. -Audited Financial Results (Standalone & Consolidated Results) for the quarter and year ended March 31, 2017. -Recommendation of equity dividend for the year 2016-17.17-May-2017
Sicagen India LimitedResultsinteralia, to consider & approve the unaudited financial results of the Company for the quarter ended June 30, 2017.06-Sep-2017
Sicagen India LimitedResultsinteralia, to consider & approve the unaudited financial results of the Company for the quarter and half year ended September 30, 201707-Dec-2017
Sicagen India LimitedResultsInter alia, to consider and approve the un-audited financial results of the Company for the quarter ended December 31, 2017.07-Feb-2018
Sicagen India LimitedFinancial Results/DividendTo consider and approve the audited financial results for the quarter and year ended March 31, 2018 and equity dividend if any recommended for the year 2017-18.15-May-2018
Sicagen India LimitedFinancial ResultsTo consider and approve the un-audited financial results of the Company for the period ended Jun 30, 2018.09-Aug-2018
Sicagen India LimitedFinancial ResultsTo inter alia, consider and approve the un-audited financial results of the Company for the quarter and half year ended September 30, 2018.22-Oct-2018
Sicagen India LimitedFinancial ResultsTo consider and approve the financial results for the period ended December 31, 201813-Feb-2019
Sicagen India LimitedFinancial ResultsTo consider and approve the financial results for the period ended March 31, 201922-May-2019
Sicagen India LimitedFinancial ResultsTo consider and approve the unfinancial results for the period ended Jun 30, 201931-Jul-2019
Sicagen India LimitedFinancial ResultsTo consider and approve the unaudited financial results for the period ended September 30, 201913-Nov-2019
Sicagen India LimitedFinancial ResultsTo consider and approve the financial results for the period ended December 31, 201907-Feb-2020
Sicagen India LimitedVoluntary DelistingTo consider and approve the proposal for voluntary delisting of equity shares of the Company from National Stock Exchange of India Ltd (NSE) as per Regulation 6(a) & 7 of the SEBI (Delisting of Equity Shares)Regulation, 2009. The equity shares of the Company will remain to be listed on Bombay stock Exchange Ltd (BSE), which has nationwide terminals.31-Mar-2020
Sicagen India LimitedVoluntary DelistingSICAGEN : 23-Apr-2020 : The Company has informed the Exchange that a Board meeting scheduled on March 31, 2020 has been now re-scheduled. Further, the Company has informed the Exchange that the meeting of the Board of Directors of the Company will be held on April 23, 2020 through Video Conference inter alia to consider and approve the proposal for voluntary delisting of shares from National Stock Exchange (NSE).31-Mar-2020
Sicagen India LimitedFinancial ResultsThe meeting of the Board of Directors of the Company has been scheduled to be held on Wednesday, the 17th June 2020 inter alia, to consider the following:-ᅡᅠAudited annual accounts of the Company for the year ended 31st March 2020.Audited financial results (standalone & consolidated results) for the quarter and year ended 31st March 2020.ᅡᅠRecommendation of equity dividend if any considered for the financial year 2019-20.ᅡᅠThe above intimation may kindly be taken on record.17-Jun-2020
Sicagen India LimitedFinancial ResultsThe meeting of the Board of Directors of the Company has been scheduled to be held on Friday, 07th August, 2020 inter alia, to consider and approve the unaudited financial results of the Company for the period ended Jun 30, 202007-Aug-2020
Sicagen India LimitedFinancial Results/Other business mattersTo consider and approve the financial results for the period ended September 30, 2020 and other business matters12-Nov-2020
Sicagen India LimitedFinancial Results/Other business mattersTo consider and approve the financial results for the period ended December 31, 2020 and other business matters10-Feb-2021
Sicagen India LimitedFinancial Results/Dividend/Other business mattersTo consider and approve the financial results for the period ended March 31, 2021, dividend and other business matters26-May-2021
Sicagen India LimitedFinancial ResultsTo consider and approve the financial results for the period ended Jun 30, 202111-Aug-2021

Share Transfers of Sicagen India Limited

CompanyPeriodReg.7Reg.40Reg7 Bcast DateReg40 Bcast Date
Sicagen India Limited31-MAR-2021 07-Apr-2021 18:40:1620-Apr-2021 12:50:05
Sicagen India Limited30-SEP-2020 19-Oct-2020 17:40:1322-Oct-2020 17:30:07
Sicagen India Limited31-MAR-2020 15-May-2020 19:30:0228-May-2020 18:10:02
Sicagen India Limited30-SEP-2019 23-Nov-2019 22:50:0424-Nov-2019 23:20:05
Sicagen India Limited31-MAR-2019 23-Apr-2019 15:12:0723-Apr-2019 15:12:07

Voting Results of Sicagen India Limited

Date of Mtg.Mtg. TypeResolutionR. requiredTotal SHs% favour% against
17-SEP-2020AGMTo receive, consider and adopt the audited Balance Sheet and Profit & Loss Account for the Year Ended March 31, 2020 together with the Reports of Directors and Auditors thereon.Ordinary422401000
17-SEP-2020AGMTo authorise the Company to advance loans, give guarantee and / or provide security in connection with any loan taken by other entities in which the Directors are interested as per Section 185 of the Companies Act, 2013.Special4224099.990.01
17-SEP-2020AGMTo ratify the appointment of Cost Auditor as per Section 148 and fixing their remuneration as an Ordinary Resolution.Ordinary422401000
17-SEP-2020AGMTo appoint a Director in the place of Mr.R.Chandrasekar (DIN: 06374821), who retires by rotation and being eligible, offers himself for re-election as an Ordinary Resolution.Ordinary422401000
17-SEP-2020AGMTo declare equity dividend for the year 2019-20.Ordinary422401000
31-JUL-2019AGMTo receive, consider and adopt Balance Sheet as at 31st March 2019, statement of profit and loss for the period on that date, reports of directors and auditors thereon.Ordinary428281000
31-JUL-2019AGMRatification of appointment of Mr.J.Karthikeyan as Cost Auditor and fixing of remuneration for financial year 2019-20Ordinary4282899.980.02
31-JUL-2019AGMTo appoint Mr.R.Chandrasekar (DIN 06374821) as Director as Whole Time Director for a period of 3 years w.e.f 28.11.2018.Special428281000
31-JUL-2019AGMTo re-appoint Mrs.Sashikala Srikanth (DIN 01678374) as Independent Director for a further period of 5 years w.e.f 11.08.2019.Special428281000
31-JUL-2019AGMTo re-appoint Mr.B.Narendran (DIN 01159394) as Independent Director for a further period of 5 years w.e.f 11.08.2019.Special4282899.980.02
31-JUL-2019AGMTo appoint Mr.M.Rajamani (DIN 00195006) as Independent Director for a period of 5 years w.e.f 28.11.2018.Special4282899.980.02
31-JUL-2019AGMTo appoint Mr.S.Radhakrishnan (DIN 00061723) as Independent Director for a period of 5 years w.e.f 09.08.2018.Ordinary4282899.980.02
31-JUL-2019AGMTo appoint Mr.S.R.Ramakrishnan (DIN 00120126) as Director of the Company.Ordinary4282899.980.02
31-JUL-2019AGMTo appoint Mr.R.Chandrasekar (DIN 06374821) as Director of the Company.Ordinary4282899.980.02
31-JUL-2019AGMTo appoint a Director in the place of Mr.Ashwin C Muthiah, who retires by rotation, being eligible and offers himself for re-election.Ordinary4282899.980.02
31-JUL-2019AGMTo declare equity dividend for the financial year 2018-19Ordinary428281000
06-AUG-2018AGMAdoption of balance sheet as at 31st March 2018, statement of profit and loss for that period, reports on directors and auditors thereon.Ordinary432741000
06-AUG-2018AGMDeclaration of equity dividend for the year 2017-18.Ordinary432741000
06-AUG-2018AGMAppointment of Director in the place of Mr.Ashwin C Muthiah who retires by rotation and being eligible for re-election.Ordinary432741000
06-AUG-2018AGMRatification of appointment of Mr.J.karthikeyan, Cost Accountant as Cost Auditor of the company and fixing of remuneration for the financial year 2018-19.Ordinary432741000

FAQs on Sicagen India Limited

Disclaimer: The information provided here is for informational purposes only and should not be considered financial advice. Please do your own research and consult with a financial professional before making any investment decisions.